Vimarsana
Biggest News Aggregation in the World

Page 37 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported the grant of stock options to purchase an aggregate of 626,000 shares of common stock...

Viracta Therapeutics Announces New Employment Inducement Grant - Vimarsana News

Viracta Therapeutics Announces New Employment Inducement Grant

SAN DIEGO, March 18, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies, today announced that the Compensation Committee of... | March 18, 2022

Viracta Therapeutics Announces New Employment Inducement Grant - Vimarsana News

Viracta Therapeutics Announces New Employment Inducement Grant

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the...

Viracta Therapeutics Announces New Employment Inducement Grant - Vimarsana News

Viracta Therapeutics Announces New Employment Inducement Grant

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the...

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors approved the grant on March 1, 2022 of a non-qualified stock option award to purchase an aggregate of 100,000 shares to Deepak Tiwari, the Company’s n...